In conclusion, prednisolone and TLR antagonist (hydroxychloroquine) may down-regulate expression levels of TLR7 and TLR9 in lupus patients, thereby decreasing the innate immune response to HPV infection. Here, TLR7 is linked to systemic lupus erythematosus.